- Home
- MNDO vs ITRM Comparison
MNDO vs ITRM Comparison
Compare MNDO & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDO
- ITRM
- Stock Information
- Founded
- MNDO 1995
- ITRM 2015
- Country
- MNDO Israel
- ITRM Ireland
- Employees
- MNDO N/A
- ITRM N/A
- Industry
- MNDO EDP Services
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- MNDO Technology
- ITRM Health Care
- Exchange
- MNDO Nasdaq
- ITRM Nasdaq
- Market Cap
- MNDO 34.2M
- ITRM 40.0M
- IPO Year
- MNDO 2000
- ITRM 2018
- Fundamental
- Price
- MNDO $1.43
- ITRM $0.87
- Analyst Decision
- MNDO
- ITRM Strong Buy
- Analyst Count
- MNDO 0
- ITRM 2
- Target Price
- MNDO N/A
- ITRM $7.00
- AVG Volume (30 Days)
- MNDO 37.7K
- ITRM 773.1K
- Earning Date
- MNDO 08-05-2025
- ITRM 08-13-2025
- Dividend Yield
- MNDO 15.22%
- ITRM N/A
- EPS Growth
- MNDO N/A
- ITRM N/A
- EPS
- MNDO 0.17
- ITRM N/A
- Revenue
- MNDO $20,677,000.00
- ITRM N/A
- Revenue This Year
- MNDO N/A
- ITRM N/A
- Revenue Next Year
- MNDO N/A
- ITRM $270.19
- P/E Ratio
- MNDO $8.50
- ITRM N/A
- Revenue Growth
- MNDO N/A
- ITRM N/A
- 52 Week Low
- MNDO $1.31
- ITRM $0.81
- 52 Week High
- MNDO $2.13
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- MNDO 57.83
- ITRM 37.57
- Support Level
- MNDO $1.40
- ITRM $0.95
- Resistance Level
- MNDO $1.52
- ITRM $1.00
- Average True Range (ATR)
- MNDO 0.06
- ITRM 0.07
- MACD
- MNDO 0.01
- ITRM -0.01
- Stochastic Oscillator
- MNDO 76.47
- ITRM 3.72
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.